These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26549757)

  • 1. Platelet - derived CD154 antigen in patients with chronic kidney disease.
    Stępniewska J; Dołęgowska B; Chruściana M; Gołembiewska E; Malinowska-Jędraszczyk A; Marchelek-Myśliwiec M; Ciechanowski K
    Clin Biochem; 2016 Feb; 49(3):243-7. PubMed ID: 26549757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet membrane CD154 and sCD154 in progressive peripheral arterial disease: a pilot study.
    Young RS; Naseem KM; Pasupathy S; Ahilathirunayagam S; Chaparala RP; Homer-Vanniasinkam S
    Atherosclerosis; 2007 Feb; 190(2):452-8. PubMed ID: 16777115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
    Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
    Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD154 is a unique predictor of nonfatal and fatal atherothrombotic events in patients who have end-stage renal disease and are on hemodialysis.
    Hocher B; Liefeldt L; Quaschning T; Kalk P; Ziebig R; Godes M; Relle K; Asmus G; Stasch JP
    J Am Soc Nephrol; 2007 Apr; 18(4):1323-30. PubMed ID: 17314326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CD40/CD40L system in Graves' disease and Hashimoto's thyroiditis related to soluble Fas, FasL and humoral markers of autoimmune response.
    Mysliwiec J; Oklota M; Nikolajuk A; Waligorski D; Gorska M
    Immunol Invest; 2007; 36(3):247-57. PubMed ID: 17558708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of sCD40 and sCD40L concentration in patients with chronic HCV infection and HIV co-infection.
    Lapiński TW; Pogorzelska J; Grzeszczuk A; Swiderska M; Kowalczuk O; Nikliński J; Flisiak R
    Przegl Epidemiol; 2014; 68(1):11-5, 105-8. PubMed ID: 25004625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.
    Henn V; Steinbach S; Büchner K; Presek P; Kroczek RA
    Blood; 2001 Aug; 98(4):1047-54. PubMed ID: 11493450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients.
    Contin C; Pitard V; Delmas Y; Pelletier N; Defrance T; Moreau JF; Merville P; Déchanet-Merville J
    Immunology; 2003 Sep; 110(1):131-40. PubMed ID: 12941150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion.
    Kaufman J; Spinelli SL; Schultz E; Blumberg N; Phipps RP
    J Thromb Haemost; 2007 Apr; 5(4):788-96. PubMed ID: 17403203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy.
    Cecerska-Heryć E; Heryć R; Dutkiewicz G; Michalczyk A; Grygorcewicz B; Serwin N; Napiontek-Balińska S; Dołęgowska B
    BMC Nephrol; 2022 Jan; 23(1):35. PubMed ID: 35042470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying sCD40 production in hemodialysis patients.
    Esposito P; Rampino T; Gregorini M; Gabanti E; Bianzina S; Dal Canton A
    Cell Immunol; 2012; 278(1-2):10-5. PubMed ID: 23121970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regenerative potential of platelets in patients with chronic kidney disease.
    Cecerska-Heryć E; Heryć R; Wiśniewska M; Michalczyk A; Dołęgowska B
    Int Urol Nephrol; 2019 Oct; 51(10):1831-1840. PubMed ID: 31197743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40.
    Delmas Y; Viallard JF; Solanilla A; Villeneuve J; Pasquet JM; Belloc F; Dubus I; Déchanet-Merville J; Merville P; Blanco P; Pellegrin JL; Nurden AT; Combe C; Ripoche J
    Kidney Int; 2005 Nov; 68(5):2068-78. PubMed ID: 16221206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet CD40 Exacerbates Atherosclerosis by Transcellular Activation of Endothelial Cells and Leukocytes.
    Gerdes N; Seijkens T; Lievens D; Kuijpers MJ; Winkels H; Projahn D; Hartwig H; Beckers L; Megens RT; Boon L; Noelle RJ; Soehnlein O; Heemskerk JW; Weber C; Lutgens E
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):482-90. PubMed ID: 26821950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The soluble CD40 ligand sCD154 in systemic lupus erythematosus.
    Kato K; Santana-Sahagún E; Rassenti LZ; Weisman MH; Tamura N; Kobayashi S; Hashimoto H; Kipps TJ
    J Clin Invest; 1999 Oct; 104(7):947-55. PubMed ID: 10510335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of platelet activation in chronic kidney disease patients on erythropoiesis-stimulating agents.
    Farag YM; Keithy-Reddy SR; Mittal BV; Bansal V; Fareed J; Singh AK
    Clin Appl Thromb Hemost; 2012 Sep; 18(5):453-61. PubMed ID: 22496088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD40 in the serum of healthy donors, patients with chronic renal failure, haemodialysis and chronic ambulatory peritoneal dialysis (CAPD) patients.
    Schwabe RF; Engelmann H; Hess S; Fricke H
    Clin Exp Immunol; 1999 Jul; 117(1):153-8. PubMed ID: 10403929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune thrombocytopenia: flow cytometric determination of platelet-associated CD154/CD40L and CD40 on peripheral blood T and B lymphocytes.
    Meabed MH; Taha GM; Mohamed SO; El-Hadidy KS
    Hematology; 2007 Aug; 12(4):301-7. PubMed ID: 17654056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil CD40 enhances platelet-mediated inflammation.
    Vanichakarn P; Blair P; Wu C; Freedman JE; Chakrabarti S
    Thromb Res; 2008; 122(3):346-58. PubMed ID: 18289643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD154 in rheumatoid arthritis: elevated plasma levels in cases with vasculitis.
    Tamura N; Kobayashi S; Kato K; Bando H; Haruta K; Oyanagi M; Kuriyama M; Kipps TJ; Hashimoto H
    J Rheumatol; 2001 Dec; 28(12):2583-90. PubMed ID: 11764201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.